Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Nuclear Medicine/Radiopharmaceuticals Market 2018, Forecast to 2023

July 2018 | 128 pages | ID: G44B0C4C00EEN
GlobalInfoResearch

Abstracts

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

SCOPE OF THE REPORT:

This report focuses on the Nuclear Medicine/Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.

The worldwide market for Nuclear Medicine/Radiopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• China Isotope & Radiation
• Dongcheng
• Jaco
• Ciaeriar
• Advanced Molecular-imaging Solution
• Shanghai Atom Kexing

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Diagnostic
• Therapeutic

Market Segment by Applications, can be divided into

• Oncology
• Thyroid
• Cardiology

There are 15 Chapters to deeply display the global Nuclear Medicine/Radiopharmaceuticals market.

Chapter 1, to describe Nuclear Medicine/Radiopharmaceuticals Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Nuclear Medicine/Radiopharmaceuticals, with sales, revenue, and price of Nuclear Medicine/Radiopharmaceuticals, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Nuclear Medicine/Radiopharmaceuticals, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Nuclear Medicine/Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceuticals sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Nuclear Medicine/Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
  1.2.1 Diagnostic
  1.2.2 Therapeutic
1.3 Market Analysis by Applications
  1.3.1 Oncology
  1.3.2 Thyroid
  1.3.3 Cardiology
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 China Isotope & Radiation
  2.1.1 Business Overview
    2.1.1.1 China Isotope & Radiation Description
    2.1.1.2 China Isotope & Radiation Headquarter, Main Business and Finance Overview
  2.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Introduction
    2.1.2.1 Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Nuclear Medicine/Radiopharmaceuticals Product Information
  2.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Market Share in 2017
2.2 Dongcheng
  2.2.1 Business Overview
    2.2.1.1 Dongcheng Description
    2.2.1.2 Dongcheng Headquarter, Main Business and Finance Overview
  2.2.2 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Introduction
    2.2.2.1 Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Nuclear Medicine/Radiopharmaceuticals Product Information
  2.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Dongcheng Nuclear Medicine/Radiopharmaceuticals Market Share in 2017
2.3 Jaco
  2.3.1 Business Overview
    2.3.1.1 Jaco Description
    2.3.1.2 Jaco Headquarter, Main Business and Finance Overview
  2.3.2 Jaco Nuclear Medicine/Radiopharmaceuticals Product Introduction
    2.3.2.1 Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Nuclear Medicine/Radiopharmaceuticals Product Information
  2.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Jaco Nuclear Medicine/Radiopharmaceuticals Market Share in 2017
2.4 Ciaeriar
  2.4.1 Business Overview
    2.4.1.1 Ciaeriar Description
    2.4.1.2 Ciaeriar Headquarter, Main Business and Finance Overview
  2.4.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Introduction
    2.4.2.1 Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Nuclear Medicine/Radiopharmaceuticals Product Information
  2.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Ciaeriar Nuclear Medicine/Radiopharmaceuticals Market Share in 2017
2.5 Advanced Molecular-imaging Solution
  2.5.1 Business Overview
    2.5.1.1 Advanced Molecular-imaging Solution Description
    2.5.1.2 Advanced Molecular-imaging Solution Headquarter, Main Business and Finance Overview
  2.5.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Introduction
    2.5.2.1 Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Nuclear Medicine/Radiopharmaceuticals Product Information
  2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Market Share in 2017
2.6 Shanghai Atom Kexing
  2.6.1 Business Overview
    2.6.1.1 Shanghai Atom Kexing Description
    2.6.1.2 Shanghai Atom Kexing Headquarter, Main Business and Finance Overview
  2.6.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Introduction
    2.6.2.1 Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Nuclear Medicine/Radiopharmaceuticals Product Information
  2.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Market Share in 2017

3 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2017
  3.4.2 Top 5 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET ANALYSIS BY REGIONS

4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Regions
  4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2013-2018)
  4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2013-2018)
4.2 North America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Countries
  5.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
  5.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
  5.1.3 United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  5.1.4 Canada Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
5.2 North America Nuclear Medicine/Radiopharmaceuticals Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2016-2017)
  5.2.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2017)
5.3 North America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Type (2013-2018)
5.4 North America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Application (2013-2018)

6 EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTICALS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Countries
  6.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
  6.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
  6.1.3 Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  6.1.4 UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  6.1.5 France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  6.1.6 Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  6.1.7 Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
6.2 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2016-2017)
  6.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2017)
6.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
  7.1.3 China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  7.1.4 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  7.1.5 Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  7.1.6 India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Countries
  8.1.1 South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
  8.1.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
  8.1.3 Brazil Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
8.2 South America Nuclear Medicine/Radiopharmaceuticals Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2016-2017)
  8.2.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2017)
8.3 South America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Type (2013-2018)
8.4 South America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  9.1.4 UAE Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SEGMENT BY TYPE

10.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type (2013-2018)
  10.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2013-2018)
10.2 Diagnostic Sales Growth and Price
  10.2.1 Global Diagnostic Sales Growth (2013-2018)
  10.2.2 Global Diagnostic Price (2013-2018)
10.3 Therapeutic Sales Growth and Price
  10.3.1 Global Therapeutic Sales Growth (2013-2018)
  10.3.2 Global Therapeutic Price (2013-2018)

11 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SEGMENT BY APPLICATION

11.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Thyroid Sales Growth (2013-2018)
11.4 Cardiology Sales Growth (2013-2018)

12 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET FORECAST (2018-2023)

12.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2018-2023)
12.2 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Regions (2018-2023)
  12.2.1 North America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
  12.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
  12.2.4 South America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
12.3 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Type (2018-2023)
  12.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2018-2023)
  12.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Type (2018-2023)
12.4 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Application (2018-2023)
  12.4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2018-2023)
  12.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Nuclear Medicine/Radiopharmaceuticals Picture
Table Product Specifications of Nuclear Medicine/Radiopharmaceuticals
Figure Global Nuclear Medicine/Radiopharmaceuticals CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Nuclear Medicine/Radiopharmaceuticals CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Types in 2017
Figure Diagnostic Picture
Table Major Manufacturers of Diagnostic
Figure Therapeutic Picture
Table Major Manufacturers of Therapeutic
Figure Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Thyroid Picture
Figure Cardiology Picture
Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure France Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure UK Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure China Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure India Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Revenue (Value) and Growth Rate (2013-2023)
Table China Isotope & Radiation Headquarter, Established, Main Business and Finance Overview (2017)
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales Market Share in 2017
Figure Global China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in 2017
Table Dongcheng Headquarter, Established, Main Business and Finance Overview (2017)
Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Product
Table Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales Market Share in 2017
Figure Global Dongcheng Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in 2017
Table Jaco Headquarter, Established, Main Business and Finance Overview (2017)
Table Jaco Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
Table Jaco Nuclear Medicine/Radiopharmaceuticals Product
Table Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Jaco Nuclear Medicine/Radiopharmaceuticals Sales Market Share in 2017
Figure Global Jaco Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in 2017
Table Ciaeriar Headquarter, Established, Main Business and Finance Overview (2017)
Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product
Table Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales Market Share in 2017
Figure Global Ciaeriar Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in 2017
Table Advanced Molecular-imaging Solution Headquarter, Established, Main Business and Finance Overview (2017)
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales Market Share in 2017
Figure Global Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in 2017
Table Shanghai Atom Kexing Headquarter, Established, Main Business and Finance Overview (2017)
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production Bases, Sales Regions and Major Competitors
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales Market Share in 2017
Figure Global Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2016-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2016
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2016-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2016
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Price by Manufacturer (2016-2017)
Figure Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions in 2013
Figure Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions in 2017
Figure North America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Figure South America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure South America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2013
Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2017
Table North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2013-2018)
Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2013
Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2017
Figure United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Canada Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Mexico Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2016-2017)
Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2016
Figure North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2017
Table North America Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2016-2017)
Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2016
Figure North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2017
Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2013-2018)
Table North America Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2016
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2017
Figure Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2016-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2016
Figure Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2017
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2016-2017)
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2016
Figure Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2017
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Type (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales by Application (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries 2017
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries 2017
Figure China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Application (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2013-2018)
Table Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2013-2018)
Figure South America Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2017
Table South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2013-2018)
Figure South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2017
Figure Brazil Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Argentina Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Colombia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2016-2017)
Figure South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2016
Figure South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2017
Table South America Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2016-2017)
Figure South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2016
Figure South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2017
Table South America Nuclear Medicine/Radiopharmaceuticals Sales by Type (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Sales by Application (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2013-2018)
Table South America Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2013-2018)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries in 2017
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2013
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries in 2017
Figure Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure UAE Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure Nigeria Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Figure South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Type (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales by Application (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2013-2018)
Table Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue Share by Application (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2013-2018)
Figure Global Diagnostic Sales Growth (2013-2018)
Figure Global Diagnostic Price (2013-2018)
Figure Global Therapeutic Sales Growth (2013-2018)
Figure Global Therapeutic Price (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Share by Application (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Thyroid Sales Growth (2013-2018)
Figure Global Cardiology Sales Growth (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2018-2023)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Regions (2018-2023)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Regions (2018-2023)
Figure North America Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
Figure Europe Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
Figure Asia-Pacific Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
Figure South America Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
Figure Middle East and Africa Sales Nuclear Medicine/Radiopharmaceuticals Market Forecast (2018-2023)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2018-2023)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Type (2018-2023)
Table Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2018-2023)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List